{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:31:47Z","timestamp":1792146707723,"version":"4.4.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,1,11]],"date-time":"2013-01-11T00:00:00Z","timestamp":1357862400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s10620-012-2524-6","type":"journal-article","created":{"date-parts":[[2013,1,10]],"date-time":"2013-01-10T16:14:00Z","timestamp":1357834440000},"page":"1627-1635","source":"Crossref","is-referenced-by-count":25,"title":["A High Level of Integrin \u03b16 Expression in Human Intrahepatic Cholangiocarcinoma Cells Is Associated with a Migratory and Invasive Phenotype"],"prefix":"10.1007","volume":"58","author":[{"given":"Yan-bing","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-sheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-ming","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-zhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-cheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-tao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,11]]},"reference":[{"key":"2524_CR1","doi-asserted-by":"crossref","unstructured":"Han SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet. 2005;366(9493):1303\u20131314.","DOI":"10.1016\/S0140-6736(05)67530-7"},{"key":"2524_CR2","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1158\/1078-0432.CCR-07-1381","volume":"14","author":"K Obama","year":"2008","unstructured":"Obama K, Satoh S, Hamamoto R, Sakai Y, Nakamura Y, Furukawa Y. Enhanced expression of RAD51 associating protein-1 is involved in the growth of intrahepatic cholangiocarcinoma cells. Clin Cancer Res. 2008;14:1333\u20131339.","journal-title":"Clin Cancer Res"},{"key":"2524_CR3","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.1002\/cncr.25485","volume":"116","author":"XY Huang","year":"2010","unstructured":"Huang XY, Ke AW, Shi GM, et al. Overexpression of CD151 as an adverse marker for intrahepatic cholangiocarcinoma patients. Cancer. 2010;116:5440\u20135451.","journal-title":"Cancer"},{"key":"2524_CR4","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.surg.2007.10.010","volume":"143","author":"MM Konstadoulakis","year":"2008","unstructured":"Konstadoulakis MM, Roayaie S, Gomatos IP, et al. Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: operative results and long-term outcome. Surgery. 2008;143:366\u2013374.","journal-title":"Surgery"},{"key":"2524_CR5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/PPO.0b013e31819e3312","volume":"15","author":"BG Jiang","year":"2009","unstructured":"Jiang BG, Sun LL, Yu WL, Tang ZH, Zong M, Zhang YJ. Retrospective analysis of histopathologic prognostic factors after hepatectomy for intrahepatic cholangiocarcinoma. Cancer J. 2009;15:257\u2013261.","journal-title":"Cancer J"},{"key":"2524_CR6","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1046\/j.1525-1373.1999.d01-122.x","volume":"222","author":"GJ Mizejewski","year":"1999","unstructured":"Mizejewski GJ. Role of integrins in cancer: survey of expression patterns. Proc Soc Exp Biol Med. 1999;222:124\u2013138.","journal-title":"Proc Soc Exp Biol Med"},{"key":"2524_CR7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc2748","volume":"10","author":"JS Desgrosellier","year":"2010","unstructured":"Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer. 2010;10:9\u201322.","journal-title":"Nat Rev Cancer"},{"key":"2524_CR8","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1091\/mbc.E06-04-0261","volume":"18","author":"MJ Edick","year":"2007","unstructured":"Edick MJ, Tesfay L, Lamb LE, Knudsen BS, Miranti CK. Inhibition of integrin-mediated crosstalk with epidermal growth factor receptor\/Erk or Src signaling pathways in autophagic prostate epithelial cells induces caspase-independent death. Mol Biol Cell. 2007;18:2481\u20132490.","journal-title":"Mol Biol Cell"},{"key":"2524_CR9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nrc727","volume":"2","author":"JD Hood","year":"2002","unstructured":"Hood JD, Cheresh DA. Role of integrins in cell invasion and migration. Nat Rev Cancer. 2002;2:91\u2013100.","journal-title":"Nat Rev Cancer"},{"key":"2524_CR10","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1083\/jcb.200302023","volume":"163","author":"N Zahir","year":"2003","unstructured":"Zahir N, Lakins JN, Russell A, et al. Autocrine laminin-5 ligates alpha6beta4 integrin and activates RAC and NFkappaB to mediate anchorage-independent survival of mammary tumors. J Cell Biol. 2003;163:1397\u20131407.","journal-title":"J Cell Biol"},{"key":"2524_CR11","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s000180050182","volume":"54","author":"P Clezardin","year":"1998","unstructured":"Clezardin P. Recent insights into the role of integrins in cancer metastasis. Cell Mol Life Sci. 1998;54:541\u2013548.","journal-title":"Cell Mol Life Sci"},{"key":"2524_CR12","doi-asserted-by":"crossref","first-page":"15559","DOI":"10.1073\/pnas.1003034107","volume":"107","author":"L Huck","year":"2010","unstructured":"Huck L, Pontier SM, Zuo DM, Muller WJ. beta1-integrin is dispensable for the induction of ErbB2 mammary tumors but plays a critical role in the metastatic phase of tumor progression. Proc Natl Acad Sci USA. 2010;107:15559\u201315564.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2524_CR13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tcb.2008.05.002","volume":"18","author":"RK Assoian","year":"2008","unstructured":"Assoian RK, Klein EA. Growth control by intracellular tension and extracellular stiffness. Trends Cell Biol. 2008;18:347\u2013352.","journal-title":"Trends Cell Biol"},{"key":"2524_CR14","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/hep.22639","volume":"49","author":"AW Ke","year":"2009","unstructured":"Ke AW, Shi GM, Zhou J, et al. Role of overexpression of CD151 and\/or c-Met in predicting prognosis of hepatocellular carcinoma. Hepatology. 2009;49:491\u2013503.","journal-title":"Hepatology"},{"key":"2524_CR15","doi-asserted-by":"crossref","unstructured":"Ke AW, Shi GM, Zhou J, et al. CD151 amplifies signaling by integrin alpha6beta1 to PI3\u00a0K and induces the epithelial-mesenchymal transition in HCC cells. Gastroenterology. 2011;140(5):1629\u20131641 e15.","DOI":"10.1053\/j.gastro.2011.02.008"},{"key":"2524_CR16","doi-asserted-by":"crossref","first-page":"298732","DOI":"10.1155\/2012\/298732","volume":"2012","author":"JR Marthick","year":"2012","unstructured":"Marthick JR, Dickinson JL. Emerging putative biomarkers: the role of alpha 2 and 6 integrins in susceptibility, treatment, and prognosis. Prostate Cancer. 2012;2012:298732.","journal-title":"Prostate Cancer"},{"key":"2524_CR17","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0092-8674(01)00567-0","volume":"107","author":"L Trusolino","year":"2001","unstructured":"Trusolino L, Bertotti A, Comoglio PM. A signaling adapter function for alpha6beta4 integrin in the control of HGF-dependent invasive growth. Cell. 2001;107:643\u2013654.","journal-title":"Cell"},{"key":"2524_CR18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0016-5085(98)70210-0","volume":"115","author":"V Carloni","year":"1998","unstructured":"Carloni V, Romanelli RG, Mercurio AM, et al. Knockout of alpha6 beta1-integrin expression reverses the transformed phenotype of hepatocarcinoma cells. Gastroenterology. 1998;115:433\u2013442.","journal-title":"Gastroenterology"},{"key":"2524_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2006.03.031","volume":"247","author":"MZ Gilcrease","year":"2007","unstructured":"Gilcrease MZ. Integrin signaling in epithelial cells. Cancer Lett. 2007;247:1\u201325.","journal-title":"Cancer Lett"},{"key":"2524_CR20","doi-asserted-by":"crossref","first-page":"6285","DOI":"10.1038\/onc.2008.304","volume":"27","author":"DA Cheresh","year":"2008","unstructured":"Cheresh DA, Stupack DG. Regulation of angiogenesis: apoptotic cues from the ECM. Oncogene. 2008;27:6285\u20136298.","journal-title":"Oncogene"},{"key":"2524_CR21","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/nrm1490","volume":"5","author":"W Guo","year":"2004","unstructured":"Guo W, Giancotti FG. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol. 2004;5:816\u2013826.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2524_CR22","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ceb.2011.08.005","volume":"23","author":"C Margadant","year":"2011","unstructured":"Margadant C, Monsuur HN, Norman JC, Sonnenberg A. Mechanisms of integrin activation and trafficking. Curr Opin Cell Biol. 2011;23:607\u2013614.","journal-title":"Curr Opin Cell Biol"},{"key":"2524_CR23","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1476-4598-10-84","volume":"10","author":"Y Wang","year":"2011","unstructured":"Wang Y, Shenouda S, Baranwal S, et al. Integrin subunits alpha5 and alpha6 regulate cell cycle by modulating the chk1 and Rb\/E2F pathways to affect breast cancer metastasis. Mol Cancer. 2011;10:84.","journal-title":"Mol Cancer"},{"key":"2524_CR24","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.yexcr.2003.11.023","volume":"294","author":"MC Demetriou","year":"2004","unstructured":"Demetriou MC, Pennington ME, Nagle RB, Cress AE. Extracellular alpha 6 integrin cleavage by urokinase-type plasminogen activator in human prostate cancer. Exp Cell Res. 2004;294:550\u2013558.","journal-title":"Exp Cell Res"},{"key":"2524_CR25","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrm1229","volume":"4","author":"K Kinbara","year":"2003","unstructured":"Kinbara K, Goldfinger LE, Hansen M, Chou FL, Ginsberg MH. Ras GTPases: integrins\u2019 friends or foes? Nat Rev Mol Cell Biol. 2003;4:767\u2013776.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2524_CR26","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nrc1075","volume":"3","author":"P Friedl","year":"2003","unstructured":"Friedl P, Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer. 2003;3:362\u2013374.","journal-title":"Nat Rev Cancer"},{"key":"2524_CR27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrc1817","volume":"6","author":"SM Janes","year":"2006","unstructured":"Janes SM, Watt FM. New roles for integrins in squamous-cell carcinoma. Nat Rev Cancer. 2006;6:175\u2013183.","journal-title":"Nat Rev Cancer"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-012-2524-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-012-2524-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-012-2524-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T04:54:18Z","timestamp":1562561658000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-012-2524-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,11]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["2524"],"URL":"https:\/\/doi.org\/10.1007\/s10620-012-2524-6","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,11]]}}}